In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable – virus detection and household transmission of SARS – CoV – 2, prevention of COVID – 19 following a single intramuscular administration of Adintrevimab, real – world effectiveness of Nirmatrelvir / Ritonavir on COVID – 19, and COVID – 19 convalescent plasma outpatient therapy to prevent outpatient hospitalization.
Visit arrow to perform
Download & nbsp, TWiV 1018( 24 MB.mp3, 39 min )
Subscribe( free ): & nbsp, Apple Podcasts, & nbsp, Google Podcasts, & nbsp, RSS, & nbsp, email
Become a & nbsp, patron & nbsp, of & nbsp, TWiV!
Backlinks for this event
- CDC vaccine advisory team recommends RSV vaccinations
- Association of culturable – virus detection and household transmission of SARS – CoV – 2( JID )
- Prevention of COVID – 19 following intramuscular administration of Adintrevimab ( OFID )
- Real – world effectiveness of Nirmatrelvir / Ritonavir on COVID – 19( CID )
- COVID – 19 convalescent plasma outpatient therapy to prevent hospitalization( CID )
- Add to our FIMRC gala at PWB
- Letters read & nbsp, on TWiV 1018
- Dr. Griffin &# 8217, s COVID treatment summary( pdf )
- Timestamps by & nbsp, Jolene. Cheers!
Intro music is by & nbsp, Ronald Jenkees
Send your questions for Dr. Griffin to daniel @ microbe.tv
The article TWiV 1018: Medical release with Dr. Daniel Griffin initially appeared on This Week in Virology.